AVTX Form 144: 65,800 Shares Notice

AVTX filed a Form 144 disclosing the proposed sale of 65,800 shares of common stock on 04/06/2026 arising from an exercise of stock options for cash.

Rhea-AI Filing Summary

AVTX filed a Form 144 disclosing the proposed sale of 65,800 shares of common stock on 04/06/2026 arising from an exercise of stock options for cash. The filing also lists recent Rule 10b5-1 sales by Mittie Doyle: 25,492 shares on 03/16/2026 and 679 shares on 04/01/2026.

Key Figures

Shares proposed for sale: 65,800 shares 10b5-1 sale (Mar): 25,492 shares 10b5-1 sale (Apr): 679 shares

3 metrics

Shares proposed for sale 65,800 shares Exercise of stock options on 04/06/2026

10b5-1 sale (Mar) 25,492 shares Sale by Mittie Doyle on 03/16/2026 for $411,606.58

10b5-1 sale (Apr) 679 shares Sale by Mittie Doyle on 04/01/2026 for $10,864.00

Key Terms

Form 144, 10b5-1, Exercise of Stock Options

3 terms

Form 144 regulatory

"144: Securities To Be Sold Common 04/06/2026 Exercise of Stock Options"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

10b5-1 regulatory

"10b5-1 Sales for MITTIE DOYLE 1500 Liberty Ridge Drive"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Exercise of Stock Options financial

"Securities To Be Sold Common 04/06/2026 Exercise of Stock Options"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the AVTX Form 144 disclose?

The Form 144 discloses a planned sale of 65,800 common shares by exercise of stock options on 04/06/2026. It also lists prior Rule 10b5-1 sales of 25,492 and 679 shares in March and April 2026.

Who executed recent 10b5-1 sales reported in the AVTX filing?

Mittie Doyle is named for Rule 10b5-1 sales of 25,492 shares on 03/16/2026 and 679 shares on 04/01/2026, with reported proceeds of $411,606.58 and $10,864.00 respectively.

What was the sale method for the 65,800 AVTX shares?

The 65,800 shares are listed as resulting from an exercise of stock options and designated as an issuer transaction on 04/06/2026, with the consideration shown as cash in the filing.

Does the AVTX Form 144 identify the exchange or listing for the shares?

Yes; the filing lists NASDAQ in the securities information section and ties the disclosed transactions to that market in the provided excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/06/2026 - 04:34 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001918845
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	AVALO THERAPEUTICS INC
SEC File Number	001-37590
Address of Issuer	1500 Liberty Ridge Drive, Suite 321 Wayne PENNSYLVANIA 19087
Phone	4105228707
Name of Person for Whose Account the Securities are To Be Sold	MITTIE DOYLE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	65800	1168608.00	22788452	04/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/06/2026	Exercise of Stock Options	Issuer			65800	04/06/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for MITTIE DOYLE 1500 Liberty Ridge Drive, Suite 321 Wayne PA 19087	Common	04/01/2026	679	10864.00
10b5-1 Sales for MITTIE DOYLE 1500 Liberty Ridge Drive, Suite 321 Wayne PA 19087	Common	03/16/2026	25492	411606.58

144: Remarks and Signature

Remarks	The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.
Date of Notice	04/06/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/13/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Mittie Doyle
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)